Related Experiment Video
Updated: Dec 26, 2025
07:24
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.9K
Addressing implicit bias in pediatric hematology-oncology
Jessica W Tsai1,2, Jennifer C Kesselheim1,2
1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Pediatric Blood & Cancer
|March 12, 2020
Summary
Implicit bias affects healthcare providers and patients, but its impact on pediatric hematology-oncology is unclear. Further research is needed to understand and address this bias in complex pediatric cancer care.
Area of Science:
- Pediatric Hematology-Oncology
- Medical Ethics
- Health Equity
Background:
- Implicit bias awareness is growing in healthcare.
- Its specific impact on pediatric hematology-oncology remains under-researched.
Observation:
- This report reviews existing literature on implicit bias in pediatrics and medical oncology.
- Case examples and potential interventions are discussed.
Findings:
- The effects of implicit bias on pediatric hematology-oncology patients require further investigation.
- Understanding these effects is crucial for improving patient care.
Implications:
- Addressing implicit bias is essential for equitable care in pediatric hematology-oncology.
- Future research should focus on mitigating bias in this specialized field.
Related Concept Videos
01:29Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
156
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
156
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
198
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
198
01:27Halo Effect
299
The halo effect is a cognitive bias in which an individual's overall impression influences judgments about their specific traits. This psychological phenomenon leads people to associate positive characteristics with those they perceive as generally good and negative characteristics with those they view as bad. This effect is particularly influential in social perception, professional evaluations, and decision-making processes.The Psychological Basis of the Halo EffectThe halo effect is rooted...
299
01:25Strategies for Assessing and Addressing Confounding
302
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
302
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
182
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
182